Literature DB >> 9317183

Aging and pharmacology.

R E Vestal1.   

Abstract

Research on aging and pharmacology in humans has been termed geriatric clinical pharmacology, which is an established subdiscipline within the broad field of clinical pharmacology. This article reviews information relevant to clinical cancer research and the care of older patients with cancer. Accordingly, the current state of knowledge on drug utilization, pharmacokinetics, pharmacodynamics, adverse drug events, drug interactions, polypharmacy, adherence to treatment, and clinical research considerations are reviewed. Although a review of the literature on aging and cancer chemotherapy is not included in this particular presentation, information is very sparse. Thus, there is significant potential for valuable contributions from clinical research through partnerships between geriatric clinical pharmacologists and medical oncologists.

Entities:  

Mesh:

Year:  1997        PMID: 9317183     DOI: 10.1002/(sici)1097-0142(19971001)80:7<1302::aid-cncr16>3.0.co;2-b

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  32 in total

Review 1.  Pharmacology of anticancer drugs in the elderly population.

Authors:  Hans Wildiers; Martin S Highley; Ernst A de Bruijn; Allan T van Oosterom
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Antithrombotic pharmacotherapy in the elderly: general issues and clinical conundrums.

Authors:  Davide Capodanno; Dominick J Angiolillo
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-02

3.  Effect of creatinine clearance on patterns of toxicity in older patients receiving adjuvant chemotherapy for breast cancer.

Authors:  Arti Hurria; Anju Hurria; Kelly Brogan; Katherine S Panageas; Carol Pearce; Larry Norton; Ann Jakubowski; Jane Howard; Clifford Hudis
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 4.  Clinical pharmacology of analgesic medicines in older people: impact of frailty and cognitive impairment.

Authors:  Andrew J McLachlan; Sally Bath; Vasi Naganathan; Sarah N Hilmer; David G Le Couteur; Stephen J Gibson; Fiona M Blyth
Journal:  Br J Clin Pharmacol       Date:  2011-03       Impact factor: 4.335

Review 5.  Systemic therapies for metastatic renal cell carcinoma in older adults.

Authors:  Sumanta K Pal; Ari Vanderwalde; Arti Hurria; Robert A Figlin
Journal:  Drugs Aging       Date:  2011-08-01       Impact factor: 3.923

6.  Safety of thalidomide in newly diagnosed elderly myeloma patients: a meta-analysis of data from individual patients in six randomized trials.

Authors:  Antonio Palumbo; Anders Waage; Cyrille Hulin; Meral Beksac; Sonja Zweegman; Francesca Gay; Peter Gimsing; Xavier Leleu; Pierre Wijermans; Gülsan Sucak; Sara Pezzatti; Gunnar Juliusson; Brigitte Pégourié; Martijn Schaafsma; Monica Galli; Ingemar Turesson; Brigitte Kolb; Bronno van der Holt; Ileana Baldi; Jürgen Rolke; Giovannino Ciccone; Marc Wetterwald; Henk Lokhorst; Mario Boccadoro; Philippe Rodon; Pieter Sonneveld
Journal:  Haematologica       Date:  2012-08-08       Impact factor: 9.941

Review 7.  Adjuvant pharmacotherapy in the management of elderly patients with pancreatic cancer.

Authors:  Raphaël Maréchal; Anne Demols; Jean-Luc Van Laethem
Journal:  Drugs Aging       Date:  2013-03       Impact factor: 3.923

8.  Non-Hodgkin's lymphoma in the elderly.

Authors:  Paolo F Caimi; Paul M Barr; Nathan A Berger; Hillard M Lazarus
Journal:  Drugs Aging       Date:  2010-03-01       Impact factor: 3.923

9.  Self-reported medication side effects in an older cohort living independently in the community--the Melbourne Longitudinal Study on Healthy Ageing (MELSHA): cross-sectional analysis of prevalence and risk factors.

Authors:  Jennifer A Thomson; Wei C Wang; Colette Browning; Hal L Kendig
Journal:  BMC Geriatr       Date:  2010-06-10       Impact factor: 3.921

10.  Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials.

Authors:  Sara Bringhen; Maria Victoria Mateos; Sonja Zweegman; Alessandra Larocca; Antonietta Pia Falcone; Albert Oriol; Davide Rossi; Maide Cavalli; Pierre Wijermans; Roberto Ria; Massimo Offidani; Juan Jose Lahuerta; Anna Marina Liberati; Roberto Mina; Vincenzo Callea; Martijn Schaafsma; Chiara Cerrato; Roberto Marasca; Luca Franceschini; Andrea Evangelista; Ana-Isabel Teruel; Bronno van der Holt; Vittorio Montefusco; Giovannino Ciccone; Mario Boccadoro; Jesus San Miguel; Pieter Sonneveld; Antonio Palumbo
Journal:  Haematologica       Date:  2013-02-26       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.